Erin Jospe, MD, and Chris Gervais of Kyruus discuss how the company partners with health care organizations to help improve their COVID-19 vaccine rollout.
The United States is now 5 months into its national vaccine rollout. Although hundreds of millions of doses have been successfully administered, the process has hit several snags along the way, including, but not limited to, disparities in administration and a failure to collect racial data on nearly half of those vaccinated at the national level.
But to achieve this feat, health systems have had to adjust to shifting vaccine eligibility requirements, ensure outreach efforts are successful, and combat misinformation within their communities, all the while scheduling appointments and making sure shots get in arms.
In an effort to meet some of the logistical challenges of the rollout, Kyruus works alongside health care organizations and provides search, scheduling, and data management solutions to help connect patients with the right care.
On this episode of Managed Care Cast, we speak with Chris Gervais, the chief technology and security officer at Kyruus, and Erin Jospe, MD, chief medical officer at Kyruus.
Listen above or through one of these podcast services:
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More